Gunduz, F. Et Al. 2022. Preliminary results of the effectiveness and safety of Tenofovir Alefenamide Fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapy. JOURNAL OF HEPATOLOGY .

Gunduz, F., DURAK, S., Unsal, Y., Demir, M., Ellik, Z. M., Yildirim, A. E., ... Mehdiyev, S.(2022). Preliminary results of the effectiveness and safety of Tenofovir Alefenamide Fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapy. JOURNAL OF HEPATOLOGY .

Gunduz, Feyza Et Al. "Preliminary results of the effectiveness and safety of Tenofovir Alefenamide Fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapy," JOURNAL OF HEPATOLOGY , 2022

Gunduz, Feyza Et Al. "Preliminary results of the effectiveness and safety of Tenofovir Alefenamide Fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapy." JOURNAL OF HEPATOLOGY , 2022

Gunduz, F. Et Al. (2022) . "Preliminary results of the effectiveness and safety of Tenofovir Alefenamide Fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapy." JOURNAL OF HEPATOLOGY .

@article{article, author={Feyza Gunduz Et Al. }, title={Preliminary results of the effectiveness and safety of Tenofovir Alefenamide Fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapy}, journal={JOURNAL OF HEPATOLOGY}, year=2022}